(Press-News.org) New Rochelle, NY, April 16, 2013—Interferons have antitumor activity and have been used to treat a variety of malignancies, including colorectal and ovarian cancers. However, their effectiveness varies. A clearer understanding of the role of interferon in immune-mediated tumor cell death and how its antitumor effects could be optimized are presented in a comprehensive Review article published in Journal of Interferon & Cytokine Research, a peer-reviewed publication from Mary Ann Liebert, Inc., publishers. The article is available free online on the Journal of Interferon & Cytokine Research website.
In the article "Immunomodulatory Effects of Interferons in Malignancies," Joseph Bekisz, Yuki Sato, Chase Johnson, Syed Husain, Raj Puri, and Kathryn Zoon, from the National Institutes of Health and the U.S. Food and Drug Administration, Bethesda, MD, discuss the implications of recent study results using interferons to treat cancer. They explore the mechanisms of interferon signaling that lead to tumor cell death and propose strategies for enhancing the therapeutic, anti-cancer effects of interferon. The authors also suggest directions for future research, including alternative methods of delivering interferon-activated immune cells.
"Interferon has long been used to treat certain types of cancer, but the mechanistic basis of successful therapy has remained elusive," says Co-Editor-in-Chief Ganes C. Sen, PhD, Chairman, Department of Molecular Genetics, Cleveland Clinic Foundation. "Here, the authors summarize results from a number of new investigations, helping to clarify our knowledge."
INFORMATION:
About the Journal
Journal of Interferon & Cytokine Research, led by Co-Editors-in-Chief Ganes C. Sen, PhD, and Thomas A. Hamilton, PhD, Chairman, Department of Immunology, Cleveland Clinic Foundation, is an authoritative peer-reviewed journal published monthly online with Open Access options and in print that covers all aspects of interferons and cytokines from basic science to clinical applications. Journal of Interferon & Cytokine Research is the Official Journal of the International Society for Interferon and Cytokine Research. Complete tables of content and a sample issue may be viewed online on the Journal of Interferon & Cytokine Research website.
About the Publisher
Mary Ann Liebert, Inc., publishers is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including Viral Immunology, AIDS Research and Human Retroviruses, and DNA and Cell Biology. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry's most widely read publication worldwide. A complete list of the firm's 70 journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc., publishers website.
New approaches to maximize the antitumor activity of interferon
2013-04-16
ELSE PRESS RELEASES FROM THIS DATE:
How does acupuncture work? The science behind the therapy explored
2013-04-16
New Rochelle, NY, April 16, 2013—Even as medical acupuncture is increasingly being validated as an effective treatment for a broad range of medical conditions, what has been missing is an understanding of the basic science and mechanisms of action of this age-old method of healing. A special issue of Medical Acupuncture, a peer-reviewed journal published by Mary Ann Liebert, Inc., publishers presents a series of articles by authors from around the world who provide diverse and insightful perspectives on the science and physiologic responses underlying medical acupuncture. ...
Energy efficiency could increase infection risks in hospital wards
2013-04-16
The chance of infection in some hospital wards varies dramatically according to whether the nurses leave the windows open.
A University of Leeds-led team studied airflow in a "Nightingale" ward—a classic hospital ward design that traditionally accommodates two rows of up to 30 beds—by using tracer gases to simulate how airborne infections spread.
They found ventilation in the ward was generally good when windows were left open, keeping the danger of airborne infection low. But risks increased fourfold when the windows were closed.
Lead investigator Dr Cath Noakes, ...
Building a better capacitor with custom nanorods
2013-04-16
A new process for growing forests of manganese dioxide nanorods may lead to the next generation of high-performance capacitors.
As an energy-storage material for batteries and capacitors, manganese dioxide has a lot going for it: it's cheap, environmentally friendly and abundant. However, chemical capacitors made with manganese dioxide have lacked the power of the typical carbon-based physical capacitor. Michigan Technological University scientist Dennis Desheng Meng theorized that the situation could be improved if the manganese dioxide were made into nanorods, which ...
Survived cancer? Now look out for cardiovascular risks
2013-04-16
WINSTON-SALEM, N.C., – April 16, 2013 – Many people survive their cancers, but end up dying of cardiovascular disease (CVD). New research from Wake Forest Baptist Medical Center finds that CVD risk factors may be overlooked during survivorship care.
Kathryn E. Weaver, Ph.D., assistant professor of social sciences and health policy at Wake Forest Baptist, and colleagues surveyed survivors of breast, prostate, colorectal and gynecologic cancers in search of answers.
"Increasingly, we are concerned about cardiovascular health in long-term cancer survivors, and we believe ...
Can computer-based decision support control health care costs?
2013-04-16
INDIANAPOLIS -- William M. Tierney, M.D. focuses on the potential of electronic medical systems and computer-based decision support to control healthcare costs in "Controlling costs with computer-based decision support: a hammer, a scalpel or an illusion?" published online in JAMA Internal Medicine on April 15.
Dr. Tierney is president and CEO of the Regenstrief Institute, associate dean for clinical effectiveness research at the Indiana University School of Medicine, chief of medicine for Wishard-Eskenazi Health, and a practicing physician.
Drawing upon his lengthy ...
Love at first sniff: Male moths go by first impressions
2013-04-16
RIVERSIDE, Calif. — An international team of researchers, including an entomologist at the University of California, Riverside, has an explanation for why we see so many hybrid moths in nature. The team closely examined the behavior and the olfactory circuitry of male moths and found an answer in female-produced pheromones — chemicals generally consisting of a blend of two to several derivatives of fatty acids.
Male moths use pheromones to find females. To avoid mating with the wrong moth species, the pheromone blends are specific for each moth species, with only males ...
Better coordination necessary to reduce hospital readmission rates
2013-04-16
Achieving widespread reductions in preventable hospital readmissions among Medicare beneficiaries may take longer than many health care professionals originally anticipated, according to researchers at Penn State, the Weill Cornell Medical College and the University of Pennsylvania.
"Studies show that one in five Medicare beneficiaries returns to the hospital within 30 days of discharge at an annual cost of $18 billion to the program, and many of these readmissions are thought to be preventable with better care," said Jessica Mittler, assistant professor of health policy ...
Methods to repair kidney cells, assess kidney function on the horizon
2013-04-16
AUGUSTA, Ga. – Researchers may have found a way to block kidney-destroying inflammation and help damaged kidney cells recover.
In a related study, they report progress on a non-invasive method to assess how much kidney function has survived a serious bout of inflammation or a chronic problem like high blood pressure.
The diagnostic tool could help physicians make hard choices about whether a patient has enough kidney function left to benefit from treatment or whether dialysis or a transplant is in their future, said Dr. Michael P. Madaio, nephrologist and Chairman of ...
New study finds digoxin safe despite recent reports
2013-04-16
CHICAGO --- A study published today in the European Heart Journal found no evidence that digoxin increases mortality in patients with atrial fibrillation (AF), the opposite of results just published by another group in the same journal analyzing the same data.
Older patients with AF also often have heart failure, and digoxin is approved to treat both conditions. AF is the most common kind of cardiac arrhythmia, an electrical malfunction that throws off the heart's rhythm and pumping rate. It may cause no symptoms or cause some patients to faint, but is seldom fatal. Heart ...
NREL survey shows dramatic improvement in B100 biodiesel quality
2013-04-16
The latest national survey of 100% biodiesel (B100) "blend stock" samples by the U.S. Department of Energy's National Renewable Energy Laboratory (NREL) found that 95% of the samples from 2011-12 met ASTM International fuel quality specifications. The ASTM standards serve as guidelines for industry and are designed to ensure quality at the pump for consumers – along with reliable operation of the nation's vehicles powered by biodiesel blends.
"The survey showed a major improvement over results from previous years," NREL Senior Chemist Teresa Alleman said. "In our 2007 ...